Aurigene Discovery Technologies Limited

This early-phase study tested an experimental oral drug called AUR105 in 17 adults with advanced solid tumors or lymphomas that had returned after prior treatment. The main goals were to check safety, find the right dose, and see how the drug moves through the body. The study was…

This early-stage study tested a new drug called AUR106 in 21 adults with advanced solid tumors (lung, stomach, bladder, kidney, colon, or esophageal cancer) that had come back or spread. The main goals were to find a safe dose and understand how the drug moves through the body. T…